| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.00071 | 1 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.00073 | 1 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.00037 | 1 |